Frequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventions.

Rapid HIV assays are the mainstay of HIV testing globally. Delivery of effective biomedical HIV prevention strategies such as antiretroviral pre-exposure prophylaxis (PrEP) requires periodic HIV testing. Because rapid tests have high (>95%) but imperfect specificity, they are expected to generate...

Full description

Bibliographic Details
Main Authors: Patrick Ndase, Connie Celum, Lara Kidoguchi, Allan Ronald, Kenneth H Fife, Elizabeth Bukusi, Deborah Donnell, Jared M Baeten, Partners PrEP Study Team
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4401675?pdf=render
id doaj-97dfc3953ce5411b9393b9d2b8e35d8f
record_format Article
spelling doaj-97dfc3953ce5411b9393b9d2b8e35d8f2020-11-24T21:34:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012300510.1371/journal.pone.0123005Frequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventions.Patrick NdaseConnie CelumLara KidoguchiAllan RonaldKenneth H FifeElizabeth BukusiDeborah DonnellJared M BaetenPartners PrEP Study TeamRapid HIV assays are the mainstay of HIV testing globally. Delivery of effective biomedical HIV prevention strategies such as antiretroviral pre-exposure prophylaxis (PrEP) requires periodic HIV testing. Because rapid tests have high (>95%) but imperfect specificity, they are expected to generate some false positive results.We assessed the frequency of true and false positive rapid results in the Partners PrEP Study, a randomized, placebo-controlled trial of PrEP. HIV testing was performed monthly using 2 rapid tests done in parallel with HIV enzyme immunoassay (EIA) confirmation following all positive rapid tests.A total of 99,009 monthly HIV tests were performed; 98,743 (99.7%) were dual-rapid HIV negative. Of the 266 visits with ≥1 positive rapid result, 99 (37.2%) had confirmatory positive EIA results (true positives), 155 (58.3%) had negative EIA results (false positives), and 12 (4.5%) had discordant EIA results. In the active PrEP arms, over two-thirds of visits with positive rapid test results were false positive results (69.2%, 110 of 159), although false positive results occurred at <1% (110/65,945) of total visits.When HIV prevalence or incidence is low due to effective HIV prevention interventions, rapid HIV tests result in a high number of false relative to true positive results, although the absolute number of false results will be low. Program roll-out for effective interventions should plan for quality assurance of HIV testing, mechanisms for confirmatory HIV testing, and counseling strategies for persons with positive rapid test results.http://europepmc.org/articles/PMC4401675?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Patrick Ndase
Connie Celum
Lara Kidoguchi
Allan Ronald
Kenneth H Fife
Elizabeth Bukusi
Deborah Donnell
Jared M Baeten
Partners PrEP Study Team
spellingShingle Patrick Ndase
Connie Celum
Lara Kidoguchi
Allan Ronald
Kenneth H Fife
Elizabeth Bukusi
Deborah Donnell
Jared M Baeten
Partners PrEP Study Team
Frequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventions.
PLoS ONE
author_facet Patrick Ndase
Connie Celum
Lara Kidoguchi
Allan Ronald
Kenneth H Fife
Elizabeth Bukusi
Deborah Donnell
Jared M Baeten
Partners PrEP Study Team
author_sort Patrick Ndase
title Frequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventions.
title_short Frequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventions.
title_full Frequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventions.
title_fullStr Frequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventions.
title_full_unstemmed Frequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventions.
title_sort frequency of false positive rapid hiv serologic tests in african men and women receiving prep for hiv prevention: implications for programmatic roll-out of biomedical interventions.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description Rapid HIV assays are the mainstay of HIV testing globally. Delivery of effective biomedical HIV prevention strategies such as antiretroviral pre-exposure prophylaxis (PrEP) requires periodic HIV testing. Because rapid tests have high (>95%) but imperfect specificity, they are expected to generate some false positive results.We assessed the frequency of true and false positive rapid results in the Partners PrEP Study, a randomized, placebo-controlled trial of PrEP. HIV testing was performed monthly using 2 rapid tests done in parallel with HIV enzyme immunoassay (EIA) confirmation following all positive rapid tests.A total of 99,009 monthly HIV tests were performed; 98,743 (99.7%) were dual-rapid HIV negative. Of the 266 visits with ≥1 positive rapid result, 99 (37.2%) had confirmatory positive EIA results (true positives), 155 (58.3%) had negative EIA results (false positives), and 12 (4.5%) had discordant EIA results. In the active PrEP arms, over two-thirds of visits with positive rapid test results were false positive results (69.2%, 110 of 159), although false positive results occurred at <1% (110/65,945) of total visits.When HIV prevalence or incidence is low due to effective HIV prevention interventions, rapid HIV tests result in a high number of false relative to true positive results, although the absolute number of false results will be low. Program roll-out for effective interventions should plan for quality assurance of HIV testing, mechanisms for confirmatory HIV testing, and counseling strategies for persons with positive rapid test results.
url http://europepmc.org/articles/PMC4401675?pdf=render
work_keys_str_mv AT patrickndase frequencyoffalsepositiverapidhivserologictestsinafricanmenandwomenreceivingprepforhivpreventionimplicationsforprogrammaticrolloutofbiomedicalinterventions
AT conniecelum frequencyoffalsepositiverapidhivserologictestsinafricanmenandwomenreceivingprepforhivpreventionimplicationsforprogrammaticrolloutofbiomedicalinterventions
AT larakidoguchi frequencyoffalsepositiverapidhivserologictestsinafricanmenandwomenreceivingprepforhivpreventionimplicationsforprogrammaticrolloutofbiomedicalinterventions
AT allanronald frequencyoffalsepositiverapidhivserologictestsinafricanmenandwomenreceivingprepforhivpreventionimplicationsforprogrammaticrolloutofbiomedicalinterventions
AT kennethhfife frequencyoffalsepositiverapidhivserologictestsinafricanmenandwomenreceivingprepforhivpreventionimplicationsforprogrammaticrolloutofbiomedicalinterventions
AT elizabethbukusi frequencyoffalsepositiverapidhivserologictestsinafricanmenandwomenreceivingprepforhivpreventionimplicationsforprogrammaticrolloutofbiomedicalinterventions
AT deborahdonnell frequencyoffalsepositiverapidhivserologictestsinafricanmenandwomenreceivingprepforhivpreventionimplicationsforprogrammaticrolloutofbiomedicalinterventions
AT jaredmbaeten frequencyoffalsepositiverapidhivserologictestsinafricanmenandwomenreceivingprepforhivpreventionimplicationsforprogrammaticrolloutofbiomedicalinterventions
AT partnersprepstudyteam frequencyoffalsepositiverapidhivserologictestsinafricanmenandwomenreceivingprepforhivpreventionimplicationsforprogrammaticrolloutofbiomedicalinterventions
_version_ 1725950587181203456